[Today's focus]

Zero Sports Auto (09863.HK)'s third-quarter revenue increased 74.3% year-on-year to 9.86 billion yuan and is expected to exceed the annual gross margin target

Zero Sports Auto (09863.HK) announced that in the third quarter of 2024, the company's revenue was RMB 9.86 billion, up 83.9% month-on-month from the second quarter and 74.3% year-on-year compared to 2023, mainly due to the significant increase in the company's product delivery volume and optimization of the product sales structure.

The gross margin for the third quarter of 2024 was 8.1%, a significant improvement from 2.8% in the second quarter of 2024. The main reasons were (1) optimization of the product sales structure; (2) ongoing cost management; and (3) the scale effect of increased sales. The average gross margin from January to September 2024 was 4.8%, and the company expects to exceed its annual gross margin target.

In the third quarter of 2024, the net loss attributable to the company's equity holders was RMB 0.69 billion, and the net loss for the same period in 2023 was RMB 0.99 billion. The losses for the third quarter narrowed sharply compared to the first and second quarters of 2024. This is a comprehensive effect of steady growth in the company's sales and revenue, continuous improvement in gross profit, and cost and expense control.

Operating cash flow for the third quarter of 2024 was RMB 1.96 billion, capital expenditure was RMB 0.64 billion, and free cash flow was RMB 1.32 billion. The company expects operating cash flow and free cash flow to continue to develop positively and positively in the fourth quarter.

[Important matters]

Hengxin Technology (01085.HK): Nanjing Zhangyu Information Technology was recognized as a gazelle enterprise

[Financial results]

Nuochengjianhua (09969.HK)'s revenue for the first three quarters increased 29.8% year-on-year, and cash reserves reached 7.8 billion yuan

Yuyuan Group (00551.HK): Net profit of 0.332 billion US dollars increased 140.9% year-on-year in the first three quarters

Han Guo Real Estate (00160.HK) Profit Warning: Expected mid-term loss of not more than HK$40 million

Baosheng International (03813.HK): Net profit increased 10.4% to 0.343 billion yuan in the first three quarters

Jianye Industrial (00216.HK) expects medium term loss of not more than HK$75 million

Liberal Arts Interactive (00434.HK) Yingxi: Profit attributable to company owners is expected to increase by about 145% to 155% in the first nine months

Binshi International (01705.HK) Profit Alert: Mid-term net profit is expected to decrease by about 35.0% to 45.0% year on year

Hong Kong Development International (00480.HK) Profit Alert: Expected medium-term loss of approximately HK$0.475 billion

[Operational data]

China Life Insurance (02628.HK)'s original premium income reached 626.9 billion yuan in January-October, up 4.9% year-on-year

Qiu Ti Technology (01478.HK)'s total camera module sales in October were 39.383 million pieces, up 16.3% month-on-month

The total trading volume of Hong Kong Science and Technology Exploration (01137.HK) orders in October 2024 reached HK$0.719 billion

Hong Kong Dragon China Land (06968.HK): Achieved a total contract sales amount of 4.509 billion yuan from January to October

Jiangshan Holdings (00295.HK): From January to October, solar power plants generated 0.2744 million megawatt-hours

Jieli Trading Bank (08017.HK): The number of registered users reached 0.8289 million in October, up 3.9% year-on-year

Baosheng International (03813.HK)'s net consolidated operating income of 1.721 billion yuan in October increased 4.7% year-on-year

[Pharmaceutical Innovation]

Bioosetu-B (02315.HK): IDEAYA nominated B7H3/PTK7 topoisomerase inhibitor payload bispecific ADC (IDE034) with similar pioneering potential as a drug candidate and exercised the right of choice

Febustat tablets owned by Shandong Xinhua Pharmaceutical Co., Ltd. (00719.HK) have obtained a drug registration certificate for long-term treatment of hyperuricemia with symptoms of gout

[Acquisition and sale]

Jacoson Pharmaceuticals (02633.HK) plans to acquire approximately 0.1 million shares of Li Zhongshengtang (Group) for HK$46.23 million

[Equity Incentives]

China Antibody-B (03681.HK) grants 10.0624 million share options to executive director Wang Shanchun

[Issuance of additional shares]

Far East Holdings International (00036.HK) proposes a “10 in 1” merger and a “1 for 2” share offering

Huayin International Holdings (00989.HK) plans to consolidate shares according to the “20 merge 1” basis

[Repurchase Cancellation]

HSBC Holdings (00005.HK) spent HK$0.285 billion to buy back 3.9728 million shares on November 8

Alibaba-SW (09988.HK) spent 19.982 million dollars to buy back 1.692 million shares on November 8

Standard Chartered Group (02888.HK) spent £13.7747 million to buy back 1.4773 million shares on November 8

Prudential (02378.HK) spent £10.3622 million to buy back 1.6 million shares on November 8

AIA (01299.HK) spent HK$62.03 million to buy back 1.026 million shares on November 11

Guangzhou Automobile Group (02238.HK) spent HK$22.0022 million to buy back 7.122 million shares on November 11

Swire Group A (00019.HK) spent HK$13.83 million to repurchase 0.212 million shares on November 11

KUAISHOU-W (01024.HK) spent HK$11.96 million to buy back 0.232 million shares on November 11

Swire Properties (01972.HK) spent HK$9.72 million to buy back 0.6 million shares on November 11

Mengniu Dairy (02319.HK) spent HK$7.0831 million to buy back 0.39 million shares on November 11

FENBI (02469.HK) cancelled 10.83 million shares on November 11

Jinyang New Energy (01121.HK) cancelled 1.014 million shares and repurchased shares on November 11